158 related articles for article (PubMed ID: 31034158)
1. MICAL-L2 potentiates Cdc42-dependent EGFR stability and promotes gastric cancer cell migration.
Min P; Zhao S; Liu L; Zhang Y; Ma Y; Zhao X; Wang Y; Song Y; Zhu C; Jiang H; Gu L; Du J
J Cell Mol Med; 2019 Jun; 23(6):4475-4488. PubMed ID: 31034158
[TBL] [Abstract][Full Text] [Related]
2. MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation.
Wang Y; Deng W; Zhang Y; Sun S; Zhao S; Chen Y; Zhao X; Liu L; Du J
Acta Physiol (Oxf); 2018 Feb; 222(2):. PubMed ID: 28719045
[TBL] [Abstract][Full Text] [Related]
3. Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition.
Zhu LY; Zhang WM; Yang XM; Cui L; Li J; Zhang YL; Wang YH; Ao JP; Ma MZ; Lu H; Ren Y; Xu SH; Yang GD; Song WW; Wang JH; Zhang XD; Zhang R; Zhang ZG
Cancer Lett; 2015 Jul; 363(1):71-82. PubMed ID: 25864591
[TBL] [Abstract][Full Text] [Related]
4. MICAL2 contributes to gastric cancer cell migration via Cdc42-dependent activation of E-cadherin/β-catenin signaling pathway.
Wang Q; Qi C; Min P; Wang Y; Ye F; Xia T; Zhang Y; Du J
Cell Commun Signal; 2022 Sep; 20(1):136. PubMed ID: 36064550
[TBL] [Abstract][Full Text] [Related]
5. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
[TBL] [Abstract][Full Text] [Related]
6. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
Hirsch DS; Shen Y; Wu WJ
Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
[TBL] [Abstract][Full Text] [Related]
7. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
Howlin J; Rosenkvist J; Andersson T
Breast Cancer Res; 2008; 10(2):R36. PubMed ID: 18435854
[TBL] [Abstract][Full Text] [Related]
8. G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor.
Si Y; Zhang H; Peng P; Zhu C; Shen J; Xiong Y; Liu X; Xiang Y; Li W; Ren Y; Wan F; Zhang L; Liu Y
Cancer Sci; 2021 Dec; 112(12):4867-4882. PubMed ID: 34609770
[TBL] [Abstract][Full Text] [Related]
9. miR-455 inhibits cell proliferation and migration via negative regulation of EGFR in human gastric cancer.
Ning T; Peng Z; Li S; Qu Y; Zhang H; Duan J; Wang X; Yang H; Liu R; Deng T; Bai M; Wang Y; Si Y; Zhang L; Wang X; Ge S; Zhou L; Ying G; Ba Y
Oncol Rep; 2017 Jul; 38(1):175-182. PubMed ID: 28535014
[TBL] [Abstract][Full Text] [Related]
10. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Cdc42 is essential for Mig-6 suppression of cell migration induced by EGF.
Jiang X; Niu M; Chen D; Chen J; Cao Y; Li X; Ying H; Bergholz J; Zhang Y; Xiao ZX
Oncotarget; 2016 Aug; 7(31):49180-49193. PubMed ID: 27341132
[TBL] [Abstract][Full Text] [Related]
12. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
[TBL] [Abstract][Full Text] [Related]
13. MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric Cancer.
Li S; Zhang H; Ning T; Wang X; Liu R; Yang H; Han Y; Deng T; Zhou L; Zhang L; Bai M; Wang X; Ge S; Ying G; Ba Y
Cell Physiol Biochem; 2016; 40(6):1303-1315. PubMed ID: 27997901
[TBL] [Abstract][Full Text] [Related]
14. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42.
Zhu Z; Yu Z; Rong Z; Luo Z; Zhang J; Qiu Z; Huang C
Theranostics; 2019; 9(26):8294-8311. PubMed ID: 31754397
[No Abstract] [Full Text] [Related]
15. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
[TBL] [Abstract][Full Text] [Related]
16. Effects of CDC42 on the proliferation and invasion of gastric cancer cells.
Du DS; Yang XZ; Wang Q; Dai WJ; Kuai WX; Liu YL; Chu D; Tang XJ
Mol Med Rep; 2016 Jan; 13(1):550-4. PubMed ID: 26549550
[TBL] [Abstract][Full Text] [Related]
17. A complex of Rab13 with MICAL-L2 and α-actinin-4 is essential for insulin-dependent GLUT4 exocytosis.
Sun Y; Jaldin-Fincati J; Liu Z; Bilan PJ; Klip A
Mol Biol Cell; 2016 Jan; 27(1):75-89. PubMed ID: 26538022
[TBL] [Abstract][Full Text] [Related]
18. Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients.
Liu JJ; Liu JY; Chen J; Wu YX; Yan P; Ji CD; Wang YX; Xiang DF; Zhang X; Zhang P; Cui YH; Wang JM; Bian XW; Qian F
Cancer Lett; 2016 Jun; 376(1):110-7. PubMed ID: 27033455
[TBL] [Abstract][Full Text] [Related]
19. CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.
Deng W; Gu L; Li X; Zheng J; Zhang Y; Duan B; Cui J; Dong J; Du J
J Transl Med; 2016 Feb; 14():32. PubMed ID: 26830684
[TBL] [Abstract][Full Text] [Related]
20. miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer.
Cheng Z; Liu F; Wang G; Li Y; Zhang H; Li F
Cell Signal; 2014 Dec; 26(12):2667-73. PubMed ID: 25152372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
